Overview
The goal of this observational study is to evaluate the long-term effect of DBS-STN on cognitive and behavioral outcomes in Parkinson's disease (PD) patients.
PD patients will be assessed over time using tests, questionnaires and standardized clinical scales. An initial assessment (T0) and annual follow-up assessments will be carried out for 5 years.
Researchers will compare data collected from patients with DBS versus patients with best medical therapy.
Eligibility
Inclusion Criteria:
- Parkinson's disease patients candidates for DBS of the subthalamic nucleus
- Parkinson's disease patients with best medical treatment
Exclusion Criteria:
- patients unable to complete study assessments